Qualified Nurse Practitioner with 19 1/2 years of experience in a leadership nursing role. Adept at critical care and management with training in patient education and leadership. Self-directed and solutions-oriented with fantastic communication skills. Committed to increasing the quality of patient care through top-of-the-line time management and prioritization.
Overview
20
20
years of professional experience
1
1
Certification
Work History
Co-Owner and Provider
Virtual Wellness Healthcare PLLC
04.2021 - Current
Responsible for the provision of direct outpatient and virtual supportive care services related to primary and urgent care issues.
Director
Gastroenterology Research Institute
01.2015 - Current
Responsible for obtaining clinical trials and enrolling subjects, negotiating research budget, ensuring reimbursement is obtained, completing the FDA requirements, obtaining IRB approval and recertification as needed, ensuring study coordinator and principal investigator follows study protocol, submitting protocol deviation as needed, acts as sub-pi in clinical trial, dispense investigational products to subjects per study protocol, ensure CITI training is completed on all individuals working on clinical trial.
Hepatology Advance Nurse Practitioner Director
Liver Wellness Center
12.2011 - Current
Responsible for the provision of direct outpatient supportive care services related to hepatic disease to include fatty liver disease, Hepatitis B, Hepatitis C, Autoimmune Hepatitis, Primary Biliary Cirrhosis, and early cirrhotic patients
In 2017 became a HIV provider for the Ryan White Foundation for mono infected and co-infection with Hepatitis C
Provider has a 5-day clinic and sees an average of 15-21 patients per day
Specific actions/responsibilities include ordering diagnostic testing as needed, completing History and Physical Assessments, assessment of daily lab and ordering appropriate intervention based on results, education of patients, families, and nursing staff regarding disease process and side effects of hepatitis c treatment, educating patients who have extensive liver disease and their family about the requirements for liver transplantation, working in collaboration with the local gastroenterology, Hepatology, primary care physician, hematologist, infectious disease physician, and hospitalists, responsible for identification, assessment, and treatment of hepatic emergencies, contributing to Gastroenterologist practice by development and presentation of Hepatitis screening and treatment power point lectures to colleagues to include attending physician, APN, nursing staff, APN students, primary care physician, and hospitalists, subscribing to and studying monthly publication of Gastroenterology and Hepatology journals to keep abreast of current practice, guidelines, and standards of care, attending various hepatology conferences both in state and out of state to keep up with the current practice and obtain CEUs for recertification, serving as Sub PI in clinical research studies for Hepatitis C, Nonalcoholic Steatohepatitis, and Primary Biliary Cirrhosis, consulting with social worker to assist with transportation issues, charitable clinics referrals, and meals on wheel for patients who require assistance to ensure patients are able to make clinical visit, able to establish care with a primary care physician, and to prevent malnutrition and dehydration during treatment, and starting the first and only Hepatitis C Support Group for the Arkansas to educate patients on nutrition needs, treatment, infectious nature of their disease process.
Hepatology Advance Nurse Practitioner
University of Arkansas for Medical Sciences
04.2006 - 12.2011
Responsible for the provision of direct outpatient supportive care services related to hepatic disease to include fatty liver disease, Hepatitis B, Hepatitis C, and early cirrhotic patients
Provider has a 5-day clinic and sees an average of 15-21 patients per day
Specific actions/responsibilities include assessment of daily lab values in response to current liver disease progression, responsible for ordering replacement of blood products, IV fluids and electrolytes as needed per laboratory data, education of patients, families, and nursing staff regarding disease process and side effects of current liver disease treatments, educating patients who have extensive liver disease and their family about the requirements for liver transplantation, working in collaboration with the local gastroenterology, Hepatology, primary care physician, hematologist, infectious disease physician, and hospitalists, directly responsible for treatment of patient with co-morbidities including CHF, bipolar disorder, schizophrenia, diabetes, hypertension, HIV, CAD, s/p liver transplant recipients, COPD, etc., responsible for identification, assessment, and treatment of hepatic emergencies, contributing to Gastroenterologist practice by development and presentation of Hepatitis screening and treatment power point lectures to colleagues to include attending physician, APN, nursing staff, APN students, primary care physician, and hospitalists, subscribing to and studying monthly publication of Gastroenterology and Hepatology journals to keep abreast of current practice, guidelines, and standards of care, attending various hepatology conferences both in state and out of state to keep up with the current practice and obtain CEUs for recertification, and responsible for daily patients' documentation and daily outpatient billing.
Nephrology Advance Nurse Practitioner
Arkansas Renal System
12.2004 - 04.2007
Responsible for the provision of direct in-patient and outpatient supportive care services related to patients with end stage renal disease
Specific actions/responsibilities include ensuring patients have knowledge of fluid and dietary restriction and the importance of attending hemodialysis appointments, organizing and continuity of care for patients being treated at the Midtown Dialysis Center with regards to length of hemodialysis, side effects associated with dialysis procedures, and diagnostic testing, working in collaboration with nephrologists, APNs, and nursing staff in the identification, assessment, analysis, and resolving of patient care issues in an inpatient setting, responsible for identification, assessment, and treatment for medical emergencies, directly responsible for treatment of patient co-morbidities including CHF, diabetes, hypertension, CAD, hypercalcemia, etc., responsible for identifying patient need for various testing including blood and fungal cultures, CT scans, MRI, EKG, Echocardiogram, etc., collaborating with Interventional Radiology for emergency Perma-cath for emergency dialysis procedures, assessment and admission of outpatients to the hospital to include written admission orders, working with bed control, and ensuring safe and efficient transition for outpatient to inpatient setting, subscribing to and studying monthly APN and nephrology journals to keep abreast to current guidelines and standard of care, responsible for daily written documentation, and serving as an advocate for patients and families regarding all patient care issues including ethical issues such as end of life issues, consulting with social worker or case coordinators to ensure that terminal patients are kept comfortable.
Cardiology Nurse Practitioner
Cardiology and Medicine Clinic
08.2005 - 05.2006
Responsible for the provision of direct in-patient supportive care services related to patients with acute cardiology issues
Specific actions/responsibilities include rounding in the inpatient settings at two local hospitals, assessing and admitting acutely ill patients with angina, congestive heart failure, atypical chest pain, cardiomyopathy, coronary artery disease, and arrhythmias into the hospital which includes writing admission orders, ordering the proper diagnostic testing and medications based on the data obtained on assessment, evaluating laboratory findings and replacing electrolytes as needed, writing discharge orders for patients being released from the hospital and discussing discharge planning with patient and their family members, and collaborating findings with physician on call.
Education
Doctor of Nursing Practice -
University of Arkansas for Medical Sciences
Little Rock, AR
05.2015
Master of Nursing Science -
University of Arkansas for Medical Sciences
Little Rock, AR
05.2005
Bachelor of Nursing Science - Registered Nurse
University of Arkansas for Medical Sciences
Little Rock, AR
05.2001
License Practical Nurse -
Pulaski Technical College
North Little Rock, AR
08.1994
Skills
Preventive Care
Patient Education
Health Promotion
Interprofessional Collaboration
Strategic Planning
Verbal and written communication
People Management
Operations Management
Certification
Arkansas Registered Nurse
Arkansas Advance Nurse Practitioner
American Nursing Credentialing Center Certification
BLS and ACLS Certification
IATA Dangerous Goods
Affiliations
Chi Eta Phi Sorority Incorporated
Sigma Theta Tau Honor Society
Speakerfaculty
Advanced Nurse Practitioner, Roche, Genentech, Schering Plough, Merck, Vertex Pharmaceuticals, Janssen Pharmaceuticals, Gilead, AbbVie Pharmaceuticals, Bristol Myers Squibb, Responsible for presenting data to colleagues that consists of physicians, medical assistants, nurse practitioner, registered nurses, substance abuse clinics regarding approved medications hepatitis c treatment and screening as per FDA approval and Pharma guidelines.
Advanced Nurse Practitioner, Intercept Pharmaceuticals, Responsible for presenting data to colleagues that consists of physicians, medical assistants, nurse practitioner, and registered nurses regarding approved medication for primary biliary cholangitis and primary biliary cirrhosis for Intercept Pharmaceuticals as per FDA approval and Pharma guidelines.
Advance Nurse Practitioner, Dova Pharmaceuticals, Responsible for presenting data to colleagues that consists of physicians, medical assistants, nurse practitioner, and registered nurses regarding approved medication for thrombocytopenia in chronic liver disease patient as per FDA approval and Pharma guidelines for Dova Pharmaceuticals.
Personal Information
Title: DNP, APRN, ACNP-BC
Publications
Norah A. Terrault, Stefan Zeuzem, Adrian M. Di Bisceglie, Joseph K. Lim, Paul J. Pockros, Lynn M. Frazier, Alexander Kuo, Anna S. Lok, Mitchell L. Shiffman, Ziv Ben Ari, Lucy Akushevich, Monika Vainorius, Mark S. Sulkowski, Michael W. Fried, David R. Nelson, Effectiveness of Ledipasvir-Sofosbuvir Combination in Patients with Hepatitis C Virus Infection and Factors Associated with Sustained Virological Response, Gastroenterology, 151, 6, 1131-1140, December 2016
Sulkowski, Mark S., Vargas, Hugo E., Di Bisceglie, Adrian M., Kuo, Alexander, Reddy, Rajender K., Lim, Joseph K., Morelli, Giuseppe, Feld, Jordan J., Brown, Robert S., Frazier, Lynn M., Fried, Michael W., Nelson, David R., Jacobson, Ira M., Safety and Efficacy of Sofosbuvir (SOF) in Combination with Simeprevir (SIM) + Ribavirin (RBV) in Patients with Genotype 1: Interim Results of a Prospective, Observational Study, Hepatology, 60, 660A-661A, October 2014
Gary P. Wang, Jackie Reeves, Norah Terrault, Joseph Lim, Giuseppe Morelli, Alexander Kuo, Josh Levitsky, Kenneth Sherman, Lynn M. Frazier, Ananthakrishnan Ramani, Joy Peter, Lucy Akuskevich, Michael W. Fried, David R. Nelson, Prevalence and Impact of Baseline Resistance-Associated Variants (RAVs) on the Efficacy of Ledipasvir/Sofosbuvir or Simeprevir/Sofosbuvir Against GT1 HCV Infection: HCV-TARGET Interim Analysis, https://www.natap.org/2016/EASL/EASL_59.htm
Welzel, T., Nelson, D., Morelli, G., Di Bisceglie, A., Reddy, R., Kuo, A., Lim, J., Darling, J., Pockros, P., Galati, J., Frazier, L., Alqahtani, S., Sulkowski, M., Vainorius, M., Akushevich, L., Fried, M., Zeuzem, S., Effectiveness and safety of sofosbuvir plus ribavirin for the treatment of HCV genotype 2 infection: results of the real-world, clinical practice HCV-TARGET study., https://doi.org/10.17615/v2jq-xc82
Feld, J., Maan, R., Zeuzem, S., Kuo, A., Nelson, D., Di Bisceglie, A., Manns, M., Sherman, K., Frazier, L., Sterling, R., Mailliard, M., Schmidt, M., Akushevich, L., Vainorius, M., Fried, M., Effectiveness and Safety of Sofosbuvir-Based Regimens for Chronic HCV Genotype 3 Infection: Results of the HCV-TARGET Study., https://doi.org/10.17615/b119-1877
Sulkowski, M. S., Vargas, H. E., Di Bisceglie, A. M., Kuo, A., Reddy, K. R., Lim, J. K., Morelli, G., Darling, J. M., Feld, J. J., Brown, R. S., Frazier, L. M., Stewart, T. G., Fried, M. W., Nelson, D. R., Jacobson, I. M., Afdhal, N., Alam, I., Ben-Ari, Z., Bredfeldt, J., ..., HCV-TARGET Study Group, Effectiveness of Simeprevir Plus Sofosbuvir, with or Without Ribavirin, in Real-World Patients with HCV Genotype 1 Infection., Gastroenterology, 150, 2, 419-429
References
Dr. John O Brandt, 151 McGowan Court, Hot Springs, Arkansas 71913, 501-623-4101